Literature DB >> 25381603

Association between circulating irisin and homocysteine in patients with nonalcoholic fatty liver disease.

Stergios A Polyzos1, Jannis Kountouras, Athanasios D Anastasilakis, Anastasia Margouta, Christos S Mantzoros.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25381603     DOI： 10.1007/s12020-014-0473-x

Source DB:  PubMed          Journal:  Endocrine        ISSN： 1355-008X            Impact factor:   3.633


× No keyword cloud information.
  15 in total

1.  Serum homocysteine levels in patients with nonalcoholic fatty liver disease.

Authors:  Stergios A Polyzos; Jannis Kountouras; Kalliopi Patsiaoura; Evangelia Katsiki; Efthimia Zafeiriadou; Georgia Deretzi; Christos Zavos; Emmanouel Gavalas; Panagiotis Katsinelos; Vasileia Mane; Aristidis Slavakis
Journal:  Ann Hepatol       Date:  2012 Jan-Feb       Impact factor: 2.400

Review 2.  Nonalcoholic fatty liver disease: multimodal treatment options for a pathogenetically multiple-hit disease.

Authors:  Stergios A Polyzos; Jannis Kountouras; Christos Zavos; Georgia Deretzi
Journal:  J Clin Gastroenterol       Date:  2012-04       Impact factor: 3.062

3.  Circulating irisin levels are not correlated with BMI, age, and other biological parameters in obese and diabetic patients.

Authors:  Fabian Sanchis-Gomar; Rafael Alis; Helios Pareja-Galeano; Eva Sola; Victor M Victor; Milagros Rocha; Antonio Hernández-Mijares; Marco Romagnoli
Journal:  Endocrine       Date:  2014-02-08       Impact factor: 3.633

Review 4.  Extrahepatic complications of nonalcoholic fatty liver disease.

Authors:  Matthew J Armstrong; Leon A Adams; Ali Canbay; Wing-Kin Syn
Journal:  Hepatology       Date:  2014-01-16       Impact factor: 17.425

5.  Design and validation of a histological scoring system for nonalcoholic fatty liver disease.

Authors:  David E Kleiner; Elizabeth M Brunt; Mark Van Natta; Cynthia Behling; Melissa J Contos; Oscar W Cummings; Linda D Ferrell; Yao-Chang Liu; Michael S Torbenson; Aynur Unalp-Arida; Matthew Yeh; Arthur J McCullough; Arun J Sanyal
Journal:  Hepatology       Date:  2005-06       Impact factor: 17.425

6.  Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis.

Authors:  David S Wald; Malcolm Law; Joan K Morris
Journal:  BMJ       Date:  2002-11-23

7.  Regulation of cell proliferation and malignant potential by irisin in endometrial, colon, thyroid and esophageal cancer cell lines.

Authors:  Hyun-Seuk Moon; Christos S Mantzoros
Journal:  Metabolism       Date:  2013-10-23       Impact factor: 8.694

8.  Association between irisin and homocysteine in euglycemic and diabetic subjects.

Authors:  Rafael Alis; Fabian Sanchis-Gomar; Helios Pareja-Galeano; Antonio Hernández-Mijares; Marco Romagnoli; Víctor M Víctor; Milagros Rocha
Journal:  Clin Biochem       Date:  2014-09-03       Impact factor: 3.281

Review 9.  NAD+ as a signaling molecule modulating metabolism.

Authors:  C Cantó; J Auwerx
Journal:  Cold Spring Harb Symp Quant Biol       Date:  2012-02-17

10.  Nicotinamide N-methyltransferase knockdown protects against diet-induced obesity.

Authors:  Daniel Kraus; Qin Yang; Dong Kong; Alexander S Banks; Lin Zhang; Joseph T Rodgers; Eija Pirinen; Thomas C Pulinilkunnil; Fengying Gong; Ya-chin Wang; Yana Cen; Anthony A Sauve; John M Asara; Odile D Peroni; Brett P Monia; Sanjay Bhanot; Leena Alhonen; Pere Puigserver; Barbara B Kahn
Journal:  Nature       Date:  2014-04-10       Impact factor: 49.962
View more
  7 in total

Review 1.  Physiology and role of irisin in glucose homeostasis.

Authors:  Nikolaos Perakakis; Georgios A Triantafyllou; José Manuel Fernández-Real; Joo Young Huh; Kyung Hee Park; Jochen Seufert; Christos S Mantzoros
Journal:  Nat Rev Endocrinol       Date:  2017-02-17       Impact factor: 43.330

Review 2.  Does iris(in) bring bad news or good news?

Authors:  Silvio Buscemi; Davide Corleo; Carola Buscemi; Carla Giordano
Journal:  Eat Weight Disord       Date:  2017-09-20       Impact factor: 4.652

3.  Serum Irisin Level Can Predict the Severity of Coronary Artery Disease in Patients with Stable Angina.

Authors:  Tolga Han Efe; Burak Açar; Ahmet Göktuğ Ertem; Kadriye Gayretli Yayla; Engin Algül; Çağrı Yayla; Sefa Ünal; Murat Bilgin; Tolga Çimen; Özgür Kirbaş; Ekrem Yeter
Journal:  Korean Circ J       Date:  2016-12-23       Impact factor: 3.243

4.  Irisin Inhibits Hepatic Cholesterol Synthesis via AMPK-SREBP2 Signaling.

Authors:  Hong Tang; Ruili Yu; Shiying Liu; Bahetiyaer Huwatibieke; Ziru Li; Weizhen Zhang
Journal:  EBioMedicine       Date:  2016-02-27       Impact factor: 8.143

5.  Association between homocysteine and non-alcoholic fatty liver disease in Chinese adults: a cross-sectional study.

Authors:  Haijiang Dai; Weijun Wang; Xiaohong Tang; Ruifang Chen; Zhiheng Chen; Yao Lu; Hong Yuan
Journal:  Nutr J       Date:  2016-12-12       Impact factor: 3.271

6.  Single nucleotide polymorphism of MTHFR rs1801133 associated with elevated Hcy levels affects susceptibility to cerebral small vessel disease.

Authors:  Hongyu Yuan; Man Fu; Xianzhang Yang; Kun Huang; Xiaoyan Ren
Journal:  PeerJ       Date:  2020-02-20       Impact factor: 2.984

Review 7.  Physiopathology of Lifestyle Interventions in Non-Alcoholic Fatty Liver Disease (NAFLD).

Authors:  David Carneros; Guillermo López-Lluch; Matilde Bustos
Journal:  Nutrients       Date:  2020-11-12       Impact factor: 5.717
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.